ShenZhen GTJA Investment Group

Qingpai Technology is a developer of photoacoustic biomedical imaging technology. It develops new clinical medical and high-end scientific research imaging platform products based on photoacoustic imaging technology, which can be used for early screening and diagnosis of breast cancer, pre-and post-operative skin flap transplantation evaluation, preoperative parathyroid detection and positioning imaging, male genital vascular imaging, skin medical cosmetology, and carotid artery plaque detection imaging.

Rosenbot provides medical robot technology and uses technological innovation to promote the reform of medical models. It is committed to creating a new generation of orthopedic surgery robot systems with intelligent fracture reduction functions, it is the first in the world to realize advanced technologies such as intraoperative real-time 3D navigation, assisted fracture reduction operation, automatic operation planning, etc. The intelligent surgical operation of the whole operation process meets the urgent needs of clinical treatment.

TOPI Imaging Technology is a medical device firm providing OCT retinal diagnostic system and sweep optical biometer.

IMPACT Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutics for cancer and other life-threatening diseases. Founded in 2009 and based in Shanghai, China, the company focuses on creating targeted anti-cancer treatments utilizing synthetic lethality. IMPACT Therapeutics is actively engaged in several research and development projects, including a PARP inhibitor, a Wee1 inhibitor, and various novel agents targeting DNA damage response mechanisms and the Hedgehog signaling pathway. Through its commitment to advancing treatment options, IMPACT Therapeutics aims to provide patients with effective and targeted anti-cancer therapies.

Kanova is a biopharmaceutical company dedicated to the development of therapeutic antibodies and innovative combination therapies, specifically targeting immuno-oncology and autoimmune diseases. The company offers a biomedical technology service platform that supports pharmaceutical research and production in the biotechnology sector. By providing antibody-based drugs that enhance immune system functionality, along with technical consultation and drug quality inspection services, Kanova enables its clients to improve drug quality and efficiently advance the field of biomedicine.

Precision Scientific is a provider of contract research organization (CRO) services aimed at enhancing cancer care for pharmaceutical and biotechnology companies. The company employs advanced AI technology, specifically its proprietary ALBERT system, which utilizes machine learning to analyze multi-omics data through data mining and predictive algorithms. This innovative approach supports oncology research by facilitating drug target discovery, biomarker identification, selection of indications, evaluation of drug resistance mechanisms, and strategies for combination therapies. Additionally, Precision Scientific offers integrated services that encompass clinical development, biomarker and companion diagnostic development, biometrics, regulatory strategy, and commercialization, catering to both pharmaceutical companies and academic or healthcare institutions.

3H Pharmaceuticals focuses on the research and development of macromolecular antibody drugs and innovative small molecules.

TenNor Therapeutics is a clinical-stage product development company dedicated to addressing unmet medical needs in the field of infectious diseases. The company utilizes a dual-acting drug discovery platform to advance a portfolio of innovative products currently in various stages of preclinical and clinical development. TenNor focuses on developing new treatments for complications arising from Helicobacter pylori infections, prosthetic joint infections, and multidrug-resistant Gram-negative infections, among other significant infectious diseases. Additionally, the company's multi-targeting approach aims to offer solutions for gastrointestinal tract infections, medical device infections, and bacterial dysbiosis, thereby providing new therapeutic options for conditions that lack effective treatments.

Atom Bioscience is a clinical-stage biotechnology company dedicated to developing innovative therapies for inflammatory and metabolic diseases. The company focuses on conditions such as chronic gout and non-alcoholic steatohepatitis (NASH), as well as metabolic disorders and certain cancers. By concentrating on the intersections of metabolism and inflammation, Atom Bioscience aims to provide patients with more effective treatment options for these challenging health issues.

Cloudbreak Therapeutics LLC, established in 2015 and based in Irvine, California, is a biotechnology company specializing in the development of ocular drugs. It focuses on repurposing approved systemic drugs for eye delivery, aiming to treat glaucoma and pterygium diseases efficiently. The company operates a capital-efficient model, utilizing contract research organizations (CROs) to maximize resources for drug development. Its business strategy involves advancing drug candidates through proof-of-concept Phase II clinical trials and subsequently out-licensing global rights for Phase III trials, registration, and commercialization.

DK Medtech is a medical technology company based in Suzhou, China, specializing in the development and production of balloon catheter medical devices. Founded in 2015, the company has positioned itself as a leader in the medical device industry, focusing on innovative solutions to address complex healthcare challenges. Through its commitment to excellence, DK Medtech aims to improve patient outcomes and enhance the quality of healthcare.

Boan Biotech is a fully integrated biopharmaceutical company dedicated to developing, manufacturing, and commercializing high-quality biologics. The company specializes in therapeutic antibodies, with a focus on key areas such as oncology, metabolism, autoimmunity, and ophthalmology. Boan Biotech operates primarily within Mainland China, generating revenue from customers in this region while also expanding its reach globally.

VivaVision Biotech is a clinical-stage R&D biopharmaceutical company that is developing novel medicines to treat topical diseases. VivaVision Biotech is dedicated to bringing new therapeutics to millions of patients suffering from chronic ocular or dermal inflammatory diseases.

Teligene Ltd., established in 2011 and headquartered in Jiangsu, China, is a pharmaceutical research and development company specializing in the creation of small-molecule drugs for oncology. The company's senior management team, experienced in advanced drug development technologies, focuses on researching and developing innovative, targeted anti-tumor drugs with independent intellectual property rights.

Lyvgen Biopharma Co. Ltd. is a biotechnology company based in Shanghai, China, focused on the research, development, and production of immuno-oncology drug candidates. Established in 2016, the company specializes in a cross-linking-dependent antibody platform that includes proprietary co-stimulation agonist biotherapeutics, such as the PD-1 antibody SSI-361. These products are designed to activate specific receptors within the tumor microenvironment while minimizing immune-mediated adverse effects on healthy tissues. In addition to its therapeutic offerings, Lyvgen Biopharma provides tumor immune agonistic antibodies and services in synthetic biology engineering, aimed at enhancing localized activation of the tumor microenvironment.

Harbour BioMed is a biotechnology company focused on discovering and developing therapeutics for cancer and inflammatory diseases. Established in 2016 with operations in Shanghai, Cambridge, and Rotterdam, the company leverages its proprietary transgenic mouse platforms to generate fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb), enabling the development of differentiated compounds such as bi-specific and multi-specific antibodies. Harbour BioMed collaborates strategically with various institutions and companies, including The Wistar Institute, WuXi Biologics, and Vir Biotechnology, to advance its pipeline of therapeutics targeting autoimmune diseases, dry eye disease, COVID-19, and other indications.

Lachesis is a high-tech company based in Shenzhen, China, specializing in clinical applications that integrate information and communications technology with internet technology. The company develops intelligent products and services aimed at enhancing the efficiency of healthcare delivery for doctors, nurses, patients, and hospitals. Its offerings include a bedside nursing solution, an interactive smart ward solution, and an IoT platform, all designed to improve management efficiency and accuracy in medical assessments. By providing mobile medical intelligent hardware and application software, Lachesis aims to advance mobile nursing and intelligent medical practices within healthcare institutions.

CF PharmTech, Inc. is an independent specialty pharmaceutical company founded in 2007 and headquartered in Suzhou, China. The company specializes in the development and manufacturing of inhalation products, including metered dose inhalers, dry powder inhalers, nasal sprays, and nebulizers. CF PharmTech focuses on creating high-quality and affordable medications for the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis. In addition to its product development efforts, the company provides contract manufacturing organization (CMO) services, enhancing its capabilities in the global market. With a commitment to effective patient care, CF PharmTech aims to improve management of respiratory conditions through its innovative offerings.

Elpiscience Biopharmaceuticals Co., Ltd. is a clinical-stage biopharmaceutical company based in Pudong, China, with an additional office in Suzhou. It specializes in developing next-generation immunotherapies aimed at treating cancer. The company boasts a robust pipeline of innovative molecules that target a wide array of challenges in immuno-oncology. Founded by experienced leaders and scientists in the biopharmaceutical field, Elpiscience is committed to advancing at least one innovative molecule into clinical trials each year, with the goal of improving treatment options for cancer patients globally.

Yao123.com is an online platform specializing in the sale of pharmaceutical products. Founded in 2015 and based in Shanghai, China, the company functions as a subsidiary of Sinopharm Group Co. Ltd. Yao123.com employs an integrated online-offline business model, allowing customers to access a wide range of health-related products conveniently. By combining digital commerce with traditional retail, the platform aims to enhance customer experience and accessibility in the pharmaceutical sector.

Sinopharm Online has a pharmaceutical retail platform to provide users with online medication consultation, medical and health management consulting services, etc. The main sales cover Chinese and Western medicines and health products. , medical equipment, Chinese medicine

Hotgen is a biotechnology company based in Beijing that specializes in the research, development, and manufacturing of innovative in-vitro diagnostic products, point-of-care testing solutions, and public safety inspection products. The company focuses on advancing liquid biopsy technology for early cancer screening and has established a multi-omics diagnostic platform that incorporates various biomolecular markers, including proteins, sugar chain exosomes, and DNA methylation. Furthermore, Hotgen's technological framework supports the deployment of diverse biopharmaceuticals such as antibody drugs, live bacteria drugs, and exosome-based therapies. Through its comprehensive development strategy, Hotgen aims to integrate the entire industry chain, facilitating advancements from diagnosis to treatment in the healthcare sector.

Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines.

Guangdong Jianke Pharmaceutical Co., Ltd. operates a network of nine pharmacy stores and an online retail platform in China. Established in 2006 and based in Dongguan, the company offers a diverse range of products, including medications for hepatobiliary, dermatology, pediatric, and urology conditions, as well as treatments for digestive, nervous, and respiratory systems. Jianke also provides female health medication, health care products, medical instruments, and beauty care items. The company focuses on addressing the needs of patients with chronic diseases through its online chronic disease management services, which complement its pharmacy offerings. Its primary revenue stream comes from online retail pharmacy services, supplemented by comprehensive medical services and tailored marketing solutions.

Lachesis is a high-tech company based in Shenzhen, China, specializing in clinical applications that integrate information and communications technology with internet technology. The company develops intelligent products and services aimed at enhancing the efficiency of healthcare delivery for doctors, nurses, patients, and hospitals. Its offerings include a bedside nursing solution, an interactive smart ward solution, and an IoT platform, all designed to improve management efficiency and accuracy in medical assessments. By providing mobile medical intelligent hardware and application software, Lachesis aims to advance mobile nursing and intelligent medical practices within healthcare institutions.

Teligene Ltd., established in 2011 and headquartered in Jiangsu, China, is a pharmaceutical research and development company specializing in the creation of small-molecule drugs for oncology. The company's senior management team, experienced in advanced drug development technologies, focuses on researching and developing innovative, targeted anti-tumor drugs with independent intellectual property rights.

Founded in 2011, 7LeKang operates nine offline stores and an online pharmacy platform

Innovative Cellular Therapeutics Co., Ltd. is a biotechnology company based in Shanghai, China, that specializes in the research and development of cell therapy. Established in 2009, the company focuses on creating chimeric antigen receptor T (CAR-T) products aimed at treating both blood cancers and solid tumors. Its development program includes innovative approaches such as allogeneic CAR-T therapies using gene editing and gene therapy techniques. Innovative Cellular Therapeutics is dedicated to advancing cellular immunotherapies that target late-stage solid tumors, including colorectal and thyroid cancers, with the goal of improving patient outcomes and supporting healthier lives.

Jabrehoo focusing on clinical transformation and innovative research and development of related products in the field of assisted reproduction, genetics and eugenics, providing one-stop solutions for reproductive genetics for assisted reproduction couples, infertile patients, and people who are preparing for pregnancy, and promoting the localization of various detections.

Singlera Genomics Inc. is a biotechnology company that specializes in genetic testing and molecular diagnostic technologies. Founded in 2014 and headquartered in La Jolla, California, with additional operations in Shanghai, China, Singlera develops a methylation detection platform designed for early cancer diagnosis and prevention. The company offers a range of services, including tumor diagnosis, personalized treatment, non-invasive prenatal diagnosis, and pre-implantation genetic screening. Additionally, Singlera is focused on advancing precision medicine, aiming to provide patients with early, accurate, and informative diagnostic solutions to improve healthcare outcomes.

CF PharmTech, Inc. is an independent specialty pharmaceutical company founded in 2007 and headquartered in Suzhou, China. The company specializes in the development and manufacturing of inhalation products, including metered dose inhalers, dry powder inhalers, nasal sprays, and nebulizers. CF PharmTech focuses on creating high-quality and affordable medications for the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis. In addition to its product development efforts, the company provides contract manufacturing organization (CMO) services, enhancing its capabilities in the global market. With a commitment to effective patient care, CF PharmTech aims to improve management of respiratory conditions through its innovative offerings.

Yunshan Medical is a private company based in Shenzhen, China, specializing in comprehensive healthcare management services. It functions as a one-stop health care service platform that integrates a range of authoritative medical expert resources. The company offers professional solutions including high-quality disease diagnosis and treatment, medical-grade physical examinations, tumor screenings, and health management. Additionally, Yunshan Medical operates medical centers and provides online customized medical services through a mobile application, allowing patients to make reservations, purchase medications, and receive medical advice, thereby enhancing access to healthcare resources.

Shanghai Henlius Biotech, Inc. is a biopharmaceutical company based in Shanghai, China, specializing in the research, development, production, and commercialization of biologics, particularly monoclonal antibody (mAb) biosimilars and novel therapies. Founded in 2010, the company focuses on oncology and autoimmune diseases, offering products such as HLX01, a biosimilar for treating non-Hodgkin lymphoma. Henlius is actively advancing its pipeline, with multiple products under review for regulatory approval, alongside conducting numerous clinical studies for various therapies. The company collaborates with partners, including agreements to develop treatments for COVID-19 and eye diseases. Shanghai Henlius Biotech is a joint venture between Shanghai Fosun Pharmaceutical and Henlius Biopharmaceuticals, established in 2009, and operates out of the Shanghai Caohejing High-Technology Park.

Annoroad Gene Technology, established in 2012 and headquartered in Beijing, is a prominent player in China's genomics industry, recognized as a leading provider of non-invasive prenatal testing (NIPT) and a distinguished medical genomics center in Asia. The company specializes in the application of next-generation sequencing technologies for human health and life science research. Annoroad has received numerous accolades, including recognition as a national high-tech enterprise and approval as a pilot organization by the National Health and Family Planning Commission for high-throughput sequencing clinical applications. With advanced proprietary genome sequencing and bioinformatics technologies, Annoroad offers a comprehensive range of services, including the NextSeq 550AR sequencer and NIPT reagent kits, facilitating diagnostic applications in human reproduction, cancer, and rare diseases. The company has established a robust presence across the entire genomics industry chain, supported by a strong talent pool and powerful bioinformatics capabilities, earning a high reputation among partners in the field.

Wellem is an operator of pediatric clinic franchise. United Wellness Pediatric Gubei Clinic (Wellem) is a private clinic that provides care for babies, children, and young adults. They believe in leveraging competition and innovation to create better care, and base their service on the American service standard. They offer general pediatrics, pediatric dental care, specialized childcare, and imported vaccines. And can help children with any issue from physical growth, to nutrition, and language to vision, and even academic skills. Parents can also bring their children for preventative check ups, with little waiting time and simple registration.

Anhui Ligoo New Energy Technology Co., Ltd. is a private company based in Hefei, China, founded in 2010. It specializes in the research, development, production, and sales of electronic control systems for new energy vehicles. Ligoo manufactures a range of products, including battery management systems, battery packs, electric drives, and charging equipment. The company is focused on enhancing the practicality and reliability of new energy vehicles, aiming to contribute to the transition of China from a major automotive consumer to a leader in automotive technology. Ligoo's innovations are designed to support the growing demand for efficient and sustainable transportation solutions globally.

Akeso Biopharma, Inc. is a contract research organization based in Zhongshan, China, specializing in the discovery and development of antibody and protein drugs. Established in 2012, the company offers a range of integrated services to both domestic and international pharmaceutical firms, including protein expression and purification, antibody generation, assay development, humanization, and affinity maturation. Akeso has developed a comprehensive biopharmaceutical research and development platform, focusing on therapeutic areas such as cancer, autoimmune diseases, inflammation, and cardiovascular diseases. With a robust pipeline of over 30 drug candidates, 17 of which are in clinical stages, Akeso is recognized for its innovative approaches, including the development of first-in-class bi-specific antibody drugs. The company collaborates with various pharmaceutical enterprises to advance the joint development of new drugs, positioning itself as a leader in the biopharmaceutical industry.

Sansure Biotech Inc. is a biotechnology company based in Changsha, Hunan Province, established in 2008. The company specializes in molecular diagnosis and genetic testing, developing and manufacturing a range of products that include nucleic acid extraction kits, real-time polymerase chain reaction (PCR) diagnostic kits, and fluorescence systems. Its product portfolio encompasses diagnostic kits for various health concerns, including novel coronavirus detection, viral hepatitis, AIDS, cancer biomarkers, and respiratory, digestive, and genetic diseases. Additionally, Sansure Biotech provides instruments and consumables to support its diagnostic offerings. The company primarily serves hospitals and laboratories both in China and internationally, focusing on enhancing diagnostic capabilities across multiple medical fields.

USCI Medical Laboratory is a national high-tech company that specializes in genetic testing services, focusing on tumor diagnosis and eugenics gene sequencing solutions. The company is dedicated to developing modern medical health solutions that encompass disease prevention, prediction, detection, interpretation, and intervention. USCI Medical Laboratory excels in batch sample detection and mass data analysis, leveraging advanced gene sequencing technologies and bioinformatics to enhance diagnostic accuracy. It also emphasizes the development of integrated multi-stage diagnostic equipment and clinical processes, providing essential technical and medical support for genomic disease screening and prevention efforts.

Anbiping is a number of reagents and supporting devices have indeed been independently created by Anbiping, which focuses on tumour screening and correct diagnosis. Pathology is the main application department. It has been established that product lines for liquid-based cytology, polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization can be used to screen for and diagnose tumors based on everything from cell morphology to protein expression.

Righton is a Shanghai-based biotechnology company specializing in genetic engineering. It focuses on the research and development of in vitro diagnostic products, including molecular diagnostic reagent kits. The company is involved in various aspects of the biotechnology field, encompassing production, sales, and scientific research, as well as providing testing services. Righton aims to contribute to advancements in molecular diagnostics through its innovative products and services.

Huayin Health Group is a medical research laboratory based in Guangzhou, China, specializing in clinical medical testing and pathological diagnosis. Established in 2009, the company offers a range of services including disease detection, clinical diagnosis for conditions such as Thalassaemia, and chromosomal genetic disease diagnosis. Additionally, Huayin Health engages in remote diagnosis and clinical research, providing high-throughput sequencing, health management, and public health testing services. The company aims to enable patients to access professional medical services tailored to their healthcare needs.

Liferiver is a PCR-based molecular diagnostic solution provider, developing, manufacturing, and marketing real-time PCR diagnostic kits as well as instruments. They offer over 400 testing kits covering most infectious diseases, genetic diseases, tumors, organ transplants, and others. Their kits are compatible with most real-time PCR systems of various brands including ABI, Bio-Rad, and Roche.

Kangnuo Pharmaceutical offers biopharmaceutical enterprise integrating R&D, production and sales. They develops, produces, and sells NAD series products.

Beijing Mabworks Biotech, a gene engineering mAb company. Mabworks is working on ZMapp, an Ebola treatment developed by San Diego's MAPP Biopharma. It also is developing two clinical stage drug candidates: MIL60, a biosimilar to Genentech's Avastin, and MIL62, a proposed treatment for chronic lymphocytic leukemia.

ARSMO Plastic Aesthetic Hospital Holding Co., Ltd., established in 2010 and based in Nanjing, China, specializes in aesthetic medical services. The hospital operates in the fields of plastic surgery, cosmetic dermatology, and dental care, providing a comprehensive range of aesthetic treatments to its clients. Originally founded as SINO-KOR Plastic and Aesthetic Hospital Investment Co., Ltd., the company rebranded to its current name in January 2015. Through its focus on enhancing physical appearance and well-being, ARSMO aims to meet the growing demand for cosmetic procedures in the region.

Royal Bio-Pharmaceutical is a company focused on the development and production of biopharmaceuticals, including therapeutic and preventive products. It specializes in creating vaccines and biological reagents that aim to address various health challenges. Through its innovative approach, Royal Bio-Pharmaceutical contributes to the advancement of healthcare solutions, emphasizing the importance of both therapeutic interventions and preventative measures in the field of medicine.

ASK e-Health is a company that specializes in developing a health management service platform designed to assist outpatients with chronic illnesses. Its flagship product, ASK-APP, is a mobile health service system that simplifies the integration of medical services for developers, allowing them to create applications without extensive coding requirements. The platform offers a comprehensive range of features including online consultation, diagnosis, data monitoring, data collection, and follow-up treatment services. By enabling patients to effectively track and monitor their health, ASK e-Health aims to reduce the recurrence rate of diseases, thereby enhancing the overall management of chronic conditions.

Danxia has the capacity to produce integrated machines. They offer forms of assistance to domestic producers while offering their clients premium products, technical assistance services.

Biovalley manufactures and sells the breviscapine series of drugs. They provide injections, capsules, tablets, dripping pills, erigeron capsules, and soft capsules. They provide solutions for ischemic cardiovascular and cerebrovascular diseases, stroke sequelae, and coronary heart disease treatment.

Vivachek is a manufacturer based in Hangzhou, specializing in high-quality blood glucose meters and related health monitoring devices. The company offers a range of products, including micro-pension blood glucose meters, glucose meter systems, blood pressure monitors, digital thermometers, and lancets. Vivachek's commitment to quality is evident in its adherence to strict regulatory standards, including China's Good Manufacturing Practice (GMP) and international standards such as ISO and FDA QSR. With an initial production facility of over 2,000 square meters, Vivachek aims to provide users with reliable tools to monitor their health and manage their glucose levels effectively.

Beijing Mabworks Biotech, a gene engineering mAb company. Mabworks is working on ZMapp, an Ebola treatment developed by San Diego's MAPP Biopharma. It also is developing two clinical stage drug candidates: MIL60, a biosimilar to Genentech's Avastin, and MIL62, a proposed treatment for chronic lymphocytic leukemia.

Vanguarj produces pharmaceutical medicine. They provide research and development, production, and sales of chemical medicines and Chinese patent medicines, external drug process research and development, production technology services, and external technology transfer.

HH Medical Diagnostics is a clinical mass spectrometry testing technology platform. They provide testing items such as accurate measurement and determination of serum vitamins, quantitative testing of amino acids and organic acids, bioequivalence, and pharmacokinetics.

Bioscience provides in vitro diagnostic medical devices and reagents intended to enhance the diagnostic capabilities of healthcare professionals. They offer products that include chemiluminescence, point-of-care testing, and supporting instruments and reagents that enable healthcare organizations to offer enhanced care.

Bioscience provides in vitro diagnostic medical devices and reagents intended to enhance the diagnostic capabilities of healthcare professionals. They offer products that include chemiluminescence, point-of-care testing, and supporting instruments and reagents that enable healthcare organizations to offer enhanced care.

Xuele Zhongguo is an online learning platform for children of primary school.

Anda Exhibition provides hall designs, construction, and operations services. They plan for exhibition halls such as museums and themed exhibition halls and offer integrated services for exhibition arrangements.

Xueleyun is an educational ecosystem platform that uses Internet technology and big data application technology to serve the education management departments, schools, teachers, students, parents, third-party partners and other seven groups.

Ximalaya Xinxi Keji is a domestic manufacturer of 3D printing equipment and a comprehensive solution provider.

Supoin is a provider of Internet of Things (IoT) data solutions, specializing in automatic identification products. The company is dedicated to enhancing the connection and communication among people, devices, and sectors through IoT technology. Supoin addresses customer needs in asset management, personnel oversight, safety supervision, and intelligent data collection. Its primary focus is on developing and manufacturing automatic bar code identification devices, which play a crucial role in the logistics, retail, and healthcare industries by facilitating the identification and storage of data related to various products.

Shenzhen Qiche Wang is a professional automotive Car networking system and product developer.

Zhongding Technology is a solution provider for intelligent logistics. They also offer technical solutions for traditional logistics.

Herun Media Group, established in 2007 and headquartered in Beijing, China, is a media company primarily engaged in advertising services. It specializes in advertising across various platforms including movies, television, the internet, 3G networks, and outdoor mediums.

Anhui Ligoo New Energy Technology Co., Ltd. is a private company based in Hefei, China, founded in 2010. It specializes in the research, development, production, and sales of electronic control systems for new energy vehicles. Ligoo manufactures a range of products, including battery management systems, battery packs, electric drives, and charging equipment. The company is focused on enhancing the practicality and reliability of new energy vehicles, aiming to contribute to the transition of China from a major automotive consumer to a leader in automotive technology. Ligoo's innovations are designed to support the growing demand for efficient and sustainable transportation solutions globally.

Boya Bio-pharmaceutical Group Co., Ltd., formerly Jiangxi Boya Bio-pharmaceutical Co., Ltd, is a China-based company principally engaged in the research, development, production and distribution of blood products.

Chamlion 3D is a national high-tech enterprise incubated and established by the Additive Manufacturing Institute of Nanjing University of Aeronautics and Astronautics. Digital solutions for dental 3D printing, leading the digital transformation and upgrading of the industry. Chenglian Technology is deeply engaged in the field of dentistry, with its in-depth understanding of the industry and rich product development.